Canfora EE, Jocken JW, Blaak EE
Clinical Evidence on Semaglutide and Ibuprofen Interactions The landscape of medication management for chronic conditions like diabetes and obesity often involves complex regimens, including the use of semaglutide for metabolic control and ibuprofen for pain management
GLP-1 receptor agonist drugs are large peptide molecules, around 3,000-4,000 Daltons, making the weight loss efficacy of GLP-1 patches ambiguous
Its unique composition promotes normalization of the microflora of the nasal mucosa, relieves puffiness and restores nasal breathing
Furthermore, sourcing introduces uncertainty in sterility and formulation integrity, which may represent a more immediate and clinically relevant risk than theoretical biologic effects, particularly given the potential for nonsterile preparation, contamination, or inconsistent formulation in nonregulated injectable products
Calder PC, et al